Watson Pharmaceuticals Financial Statements
Watson Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Watson Pharmaceuticals Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 2,535.5 | 2,496.7 | 1,979.2 |
| Gross Profit ($ mil.) | 1,032.7 | 991.9 | 745.8 |
| Operating Income ($ mil.) | 386.5 | 268.8 | (388.9) |
| Total Net Income ($ mil.) | 238.4 | 141.0 | (445.0) |
| Diluted EPS (Net Income) | 2.09 | 1.27 | (4.37) |
Watson Pharmaceuticals Quarterly Statements
| Quarter Ending Mar 09 | Quarter Ending Dec 08 | Quarter Ending Sep 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 667.4 | 645.2 | 640.7 |
| Gross Profit ($ mil.) | 278.7 | 269.1 | 254.0 |
| Operating Income ($ mil.) | 84.7 | 94.1 | 101.0 |
| Total Net Income ($ mil.) | 49.1 | 56.4 | 71.1 |
| Diluted EPS (Net Income) | 0.43 | 0.49 | 0.62 |
Watson Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.52 | 2.55 | 5.93 |
| Price/Earnings Ratio | 16.53 | 12.55 | 21.55 |
| Price/Book Ratio | 1.62 | 3.29 | 5.70 |
| Price/Cash Flow Ratio | 9.33 | 10.62 | 36.90 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Watson Pharmaceuticals Financial Ratios
Watson Pharmaceuticals Competitive Intelligence
| Barr Pharmaceuticals | Mylan | Teva Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 0.0 | 5,137.6 | 11,085.0 |
| Employees | 8,900 | 15,000 | 38,307 |
| Market Cap ($ mil.) | -- | 4,093.7 | 44,169.5 |
Competitive Landscape